Profilo
Sofien Dessolin is the founder of Cell&Co SAS.
He held the titles of Chairman, CFO & Chief Scientific Officer at the company.
Posizioni attive di Sofien Dessolin
| Società | Posizione | Inizio |
|---|---|---|
Cell&Co SAS
 Cell&Co SAS Miscellaneous Commercial ServicesCommercial Services Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Cell&Co SAS
Cell&Co SAS Miscellaneous Commercial ServicesCommercial Services Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million. | Commercial Services |
- Borsa valori
- Insiders
- Sofien Dessolin
